se of Autologous bone marrow stem cell transplantation therapy in the treatment of Chronic Renal Failure in 5 indian patients. ABMST-CRF Study (Autologous Bone marrow Stem cell Transplantation-CRF).

International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 5600640 个研究点目标入组 5 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Must be able to give voluntary written (patients may not be able to write) consent.
•2. Must be able to understand study information provided to him.
•3. CKD patients of stage IV and ESRD with age 18 to 65 years.
•4. Patient should be afebrile 24 hours prior to procedure.

•1.Women who are pregnant or lactating
•2.Acute Renal Failure
•3.Severe co-morbidities like cardiac insufficiency, congestive cardicac failure, malignancy, infection, sepsis and bed sores.
•4.Haemoglobin level below 8g %
•5.Chronic kidney disease due to autoimmune aetiology, connective tissue disease, amyloidosis and storage disorders.
•6.Known bleeding or coagulation disorder
•7.Known hematologic disease
•8.Poorly controlled hypertension
•9.Evidence of active malignancy within one year prior to randomization.
•10.Severe skin infection or osteomyelitis - the site of bone marrow aspiration potentially limiting the procedure.
•11.Have a known allergy to iodinated contrast
•12.Positive test results for HIV and AIDS complex.
•13.History of drug or alcohol abuse
•14.Patients on immunosuppressive therapy.

发起方

International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 560064